Research & Development
Policy & Regulation
Trends & Finance
Guideline: Page 3
Study: less than half of pregnant people screened for HCV
Quest noted that the CDC and the U.S. Preventive Services Task Force (USPSTF) published guidelines in early 2020 acknowledging the value of HCV antibody screening in response to growing rates of infection. A significant increase in screening was seen following the guidelines but many patients are still not receiving the recommended testing, Quest noted.
June 12, 2022
ASCO presentation highlights clinical utility of ctDNA testing
Findings from the study were presented Saturday at the annual meeting of the American Society of Clinical Oncology and published in the New England Journal of Medicine.
June 5, 2022
Labcorp launches skin cancer assay
Studies have shown that LAG-3 is an immune-oncology target with demonstrable clinical benefit in patients with melanoma. Labcorp said its LAG-3 IHC method has demonstrated performance suitable for analysis of LAG-3 immune cell expression in clinical melanoma samples in a study published May 9 in the Journal of Clinical Pathology.
May 18, 2022
Diadem highlights new study on AlzoSure test for Alzheimer's
In a retrospective study published online May 17 in the Journal of Prevention of Alzheimer's Disease, researchers reported that AlzoSure Predict achieved an area under the curve (AUC) of more than 0.98 for identifying people who would progress to future symptomatic Alzheimer's disease up to six years before diagnosis.
May 17, 2022
Dalrada Health completes cervical cancer screening kit trial
Results from the trial were published this month in the Indian Society of Perinatology and Reproductive Biology (IJOPARB) journal. Study participants were screened for cervical cancer with cerVIA, which showed an accuracy of 91%, according to the firm. The test is patent-pending, Dalrada said.
April 24, 2022
Lucid promotes new guideline from ACG on esophageal cancer
The new guidelines include a reference to screening for esophageal cancer using Lucid's EsoGuard DNA test on samples collected with its EsoCheck Cell Collection device, it said.
April 3, 2022
Guardant to highlight cancer screening studies at AACR
Key presentations will include data from Guardant's multicancer screening assay, Guardant Shield.
March 9, 2022
Article supports FDA review of lab-developed tests
The U.S. Department of Health and Human Services (HHS) in August 2020 ruled that LDTs to diagnose whether patients are infected with SARS-CoV-2 did not have to undergo review by the FDA.
March 7, 2022
AI of chest x-rays finds TB when lab tests fall short
As part of the End TB strategy, the World Health Organization (WHO) has recommended the use of chest x-ray as a screening and triage tool where bacteriological diagnostic tests are unclear. Inconclusive TB tests are common in children due to their lower bacteria counts, according to the WHO. The strategy also states that lateral chest x-ray views may be needed in cases of a challenging bacteriological confirmation in younger children.
March 6, 2022
Cancer group recommends 9 ways to boost cancer screenings
The new report, "Responding to the COVID-19 Pandemic: Improving Cancer Screening and Care in the U.S.," aims to address the number of patients who have missed baseline cancer screenings due to the pandemic.
February 15, 2022
Bio-Techne touts study with ExoDx prostate test
In men with an EPI score below 15.6, the test could prevent those at low risk from proceeding to radical prostatectomy, according to a study published January 27 in the World Journal of Urology.
February 15, 2022
AMP names new editor in chief for its journal
Przygodzki will be replacing Barbara Zehnbauer, PhD, who has been the journal's EIC since January 2015. APM said that Zehnbauer "served with distinction" during her tenure as EIC. In 2020, the journal had an impact factor of 5.568 and its most recent CiteScore in 2020 is 8.0.
February 13, 2022
Page 3 of 8